Baillie Gifford Health Inn Eq Instl BGHBX

Medalist Rating as of | See Baillie Gifford Investment Hub
  • NAV / 1-Day Return 5.98  /  0.00
  • Total Assets 6.8 Mil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Mid Growth
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.00
  • Turnover 23%

USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:12 PM GMT+0

Morningstar’s Analysis BGHBX

Will BGHBX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Baillie Gifford Health Inn Eq Instl's recent People Pillar rating upgrade outweighs the negative impact of its fee hike, resulting in an improvement in its Morningstar Medalist Rating to Neutral from Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BGHBX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 53.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Alnylam Pharmaceuticals Inc

7.05 1.1 Mil
Healthcare

Moderna Inc

6.93 1.1 Mil
Healthcare

argenx SE

6.40 1.0 Mil
Healthcare

Alk-Abello A/S Class B

5.52 883,369
Healthcare

Ambu A/S Class B

5.23 837,909
Healthcare

DexCom Inc

4.88 781,755
Healthcare

Edwards Lifesciences Corp

4.82 771,474
Healthcare

Genmab A/S

4.77 763,384
Healthcare

Ionis Pharmaceuticals Inc

3.95 632,877
Healthcare

Insulet Corp

3.53 565,444
Healthcare

Sponsor Center